[Experimental lesions of the myocardium: role of alterations of energetic metabolism].
D000818:Animals; D001013:Aorta, Thoracic; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D009202:Cardiomyopathies / Q000139:chemically induced / Q000209:etiology / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism; D004558:Electric Stimulation; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D008929:Mitochondria, Heart / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000009:adverse effects; D010101:Oxygen Consumption; D010725:Phosphocreatine / Q000378:metabolism; D010758:Phosphorus / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013312:Stress, Physiological / Q000150:complications
D010725:Phosphocreatine; D010758:Phosphorus; D007980:Levodopa; D000242:Cyclic AMP; D009638:Norepinephrine
Lesioni sperimentali del miocardio: buolo delle alterazioni del metabolismo energetico.